SEC Form 4 · accession 0001213900-18-016050
Icagen, Inc. · ICGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Roffman
Director
Period of report
Nov 14, 2018
Accepted (ET)
Nov 16, 2018 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001518520
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $3.50 | Nov 14, 2018 | A | 25,000 | A | Nov 14, 2018 | Nov 14, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option vests as to 12, 500 shares of common stock immediately and the remaining 12,500 shares of common stock on the one year anniversary of the date of grant.